Copyright
©The Author(s) 2005.
World J Gastroenterol. Jul 21, 2005; 11(27): 4194-4198
Published online Jul 21, 2005. doi: 10.3748/wjg.v11.i27.4194
Published online Jul 21, 2005. doi: 10.3748/wjg.v11.i27.4194
Table 1 TAC and CTAC in patients and controls
| Group | TAC (mmol/L) | CTAC (mmol/L) |
| Control | 1.493 ± 0.059 | 0.797 ± 0.057 |
| Cirrhotics | 1.532 ± 0.095 | 0.723 ± 0.069 |
| PBC | 1.664 ± 0.062 | 1.012 ± 0.068 |
| PBC I–II | 1.691 ± 0.080 | 1.096 ± 0.077 |
| PBC III–IV | 1.593 ± 0.086 | 0.789 ± 0.117 |
| CAH | 1.477 ± 0.080 | 0.875 ± 0.072 |
- Citation: Notas G, Miliaraki N, Kampa M, Dimoulios F, Matrella E, Hatzidakis A, Castanas E, Kouroumalis E. Patients with primary biliary cirrhosis have increased serum total antioxidant capacity measured with the crocin bleaching assay. World J Gastroenterol 2005; 11(27): 4194-4198
- URL: https://www.wjgnet.com/1007-9327/full/v11/i27/4194.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i27.4194